THZ1, 5mg
To Order Contact us: lieven@wlsolutions.be
THZ1 Hydrochloride |
||
B4736-10 | 10 mg | EUR 268.8 |
Description: THZ1 is a covalent inhibitor of CDK7 with IC50 value of 3.2nM [1].THZ1 covalently modifies CDK7 by targeting C312 residue outside of the kinase domain, providing an unanticipated means of achieving covalent selectivity. |
THZ1 Hydrochloride |
||
B4736-25 | 25 mg | EUR 477.6 |
Description: THZ1 is a covalent inhibitor of CDK7 with IC50 value of 3.2nM [1].THZ1 covalently modifies CDK7 by targeting C312 residue outside of the kinase domain, providing an unanticipated means of achieving covalent selectivity. |
THZ1 Hydrochloride |
||
B4736-5 | 5 mg | EUR 170.4 |
Description: THZ1 is a covalent inhibitor of CDK7 with IC50 value of 3.2nM [1].THZ1 covalently modifies CDK7 by targeting C312 residue outside of the kinase domain, providing an unanticipated means of achieving covalent selectivity. |
THZ1 Hydrochloride |
||
B4736-5.1 | 10 mM (in 1mL DMSO) | EUR 205.2 |
Description: THZ1 is a covalent inhibitor of CDK7 with IC50 value of 3.2nM [1].THZ1 covalently modifies CDK7 by targeting C312 residue outside of the kinase domain, providing an unanticipated means of achieving covalent selectivity. |
THZ1 hydrochloride |
||
9544-25 | each | EUR 1227.6 |
THZ1 hydrochloride |
||
9544-5 | each | EUR 366 |
THZ1 (Hydrochloride) |
||
HY-80013A | 5mg | EUR 192 |
THZ1 (Free base) |
||
9664-25 | each | EUR 1227.6 |
THZ1 (Free base) |
||
9664-5 | each | EUR 352.8 |
L-NIL: (5mg) |
||
00242 | 5MG | EUR 206.4 |
Description: Minimum order quantity: 1 unit of 5MG |
L-NIO: (5mg) |
||
00243 | 5MG | EUR 206.4 |
Description: Minimum order quantity: 1 unit of 5MG |
RuBP-4S: (5mg) |
||
80025 | 5MG | EUR 286.8 |
Description: Minimum order quantity: 1 unit of 5MG |
Mitomycin C, 5mg |
||
R5007-5mg | each | EUR 270 |
SynaptoRed C1: (5mg) |
||
70040 | 5MG | EUR 333.6 |
Description: Minimum order quantity: 1 unit of 5MG |
SynaptoGreen C3: (5mg) |
||
70023 | 5MG | EUR 333.6 |
Description: Minimum order quantity: 1 unit of 5MG |
SynaptoGreen C5: (5mg) |
||
70046 | 5MG | EUR 333.6 |
Description: Minimum order quantity: 1 unit of 5MG |
Rhodamine-DHPE: (5mg) |
||
60026 | 5MG | EUR 271.2 |
Description: Minimum order quantity: 1 unit of 5MG |
SynaptoGreenTM C1: (5mg) |
||
70042 | 5MG | EUR 333.6 |
Description: Minimum order quantity: 1 unit of 5MG |
Fluorescein-DHPE: (5mg) |
||
60024 | 5MG | EUR 271.2 |
Description: Minimum order quantity: 1 unit of 5MG |
THZ531 |
||
A8736-25 | 25 mg | EUR 2844 |
Description: THZ531 is a first-in-class CDK12 and CDK13 covalent inhibitor with IC50 values of 158 nM and 69 nM, respectively [1]. Complexes containing CDK12 and CDK13 regulate transcriptional elongation as well as processes, including mRNA splicing and 3?-end RNA processing. |
THZ531 |
||
A8736-5 | 5 mg | EUR 1034.4 |
Description: THZ531 is a first-in-class CDK12 and CDK13 covalent inhibitor with IC50 values of 158 nM and 69 nM, respectively [1]. Complexes containing CDK12 and CDK13 regulate transcriptional elongation as well as processes, including mRNA splicing and 3?-end RNA processing. |
THZ531 |
||
HY-103618 | 50mg | EUR 1011.6 |
Biotin-X-DHPE: (5mg) |
||
60023 | 5MG | EUR 284.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Arachidonic Acid 5mg/ml |
||
ABP-ARA-1 | 3 x 0,5ml vials | EUR 68.4 |
Amersham Cy5 Maleimide 5mg |
||
PA15130 | EACH | EUR 1237.2 |
Linear Polyacrylamide (5mg/ml) |
||
S143 | 1 ml | EUR 48 |
Aminooxy-5(6)-ROX: (5mg) |
||
90104 | 5MG | EUR 290.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Phosphate Test 0.5-5mg/L |
||
WAT3653 | EACH | EUR 213.7 |
THZ2 |
||
A8717-10 | 10 mg | EUR 756 |
Description: THZ2 is a potent and selective CDK7 inhibitor (IC50=13.9 nM).Cyclin-dependent kinase (CDK) is a group of serine/threonine kinases. |
THZ2 |
||
A8717-100 | 100 mg | EUR 2983.2 |
Description: THZ2 is a potent and selective CDK7 inhibitor (IC50=13.9 nM).Cyclin-dependent kinase (CDK) is a group of serine/threonine kinases. |
THZ2 |
||
A8717-5 | 5 mg | EUR 547.2 |
Description: THZ2 is a potent and selective CDK7 inhibitor (IC50=13.9 nM).Cyclin-dependent kinase (CDK) is a group of serine/threonine kinases. |
THZ2 |
||
A8717-5.1 | 10 mM (in 1mL DMSO) | EUR 1047.6 |
Description: THZ2 is a potent and selective CDK7 inhibitor (IC50=13.9 nM).Cyclin-dependent kinase (CDK) is a group of serine/threonine kinases. |
THZ2 |
||
A8717-50 | 50 mg | EUR 2148 |
Description: THZ2 is a potent and selective CDK7 inhibitor (IC50=13.9 nM).Cyclin-dependent kinase (CDK) is a group of serine/threonine kinases. |
THZ2 |
||
HY-12280 | 100mg | EUR 1988.4 |
5-TAMRA-PEO3-amine: (5mg) |
||
90107 | 5MG | EUR 446.4 |
Description: Minimum order quantity: 1 unit of 5MG |
PNPP sodium salt, 5mg tablets |
||
GX3711-100EA | 100 EA | EUR 302.4 |
PNPP sodium salt, 5mg tablets |
||
GX3711-100 | 100 | EUR 219.7 |
Phosphorus Reactive 0-5mg/L |
||
WAT1036 | EACH | EUR 96 |
DMNPE-Caged D-Luciferin: (5mg) |
||
10103 | 5MG | EUR 177.6 |
Description: Minimum order quantity: 1 unit of 5MG |
BD fibronectin human plasma 5mg |
||
356008 | EACH | EUR 548.4 |
Biotin-X-C5-maleimide: (5mg) |
||
90058 | 5MG | EUR 225.6 |
Description: Minimum order quantity: 1 unit of 5MG |
neo PRP MPlate Pop Plate 5mg |
||
CHR5938 | EACH | EUR 325.2 |
neo PCX MPlate Pop Plate 5mg |
||
CHR5946 | EACH | EUR 334.8 |
Amersham Cy3 Bis NHS ester 5mg |
||
PA13000 | EACH | EUR 1315.2 |
Amersham Cy5 Bis NHS ester 5mg |
||
PA15000 | EACH | EUR 1293.6 |
Amersham Cy7 Bis NHS ester 5mg |
||
PA17000 | EACH | EUR 1315.2 |
Amersham Cy3 Mono NHS ester 5mg |
||
PA13105 | EACH | EUR 1310.4 |
Amersham Cy5 mono NHS ester 5mg |
||
PA15100 | EACH | EUR 1542 |
Amersham Cy5.5 mono NHS ester 5mg |
||
PA15605 | EACH | EUR 1237.2 |
Amersham Cy7 mono NHS ester 5mg |
||
PA17105 | EACH | EUR 1297.2 |
5(6)-CR110-C5-Maleimide: (5mg) |
||
91029 | 5MG | EUR 501.6 |
Description: Minimum order quantity: 1 unit of 5MG |
Free Chlorine Reagents 0-5mg/L |
||
WAT1028 | EACH | EUR 44.4 |
Albumin Standard Ampules (5mg / ml BSA) |
||
abx090645-1ml | 1 ml | EUR 210 |
5-CR110-PEO4-Propionate, SE:5mg |
||
90081 | 5MG | EUR 574.8 |
Description: Minimum order quantity: 1 unit of 5MG |
Chlorine Indicator Strips 0-5mg/L |
||
PAP1226 | PK100 | EUR 24 |
Linear Poly Acrylamide Solution (5mg/ml) |
||
LK548 | 1ml | EUR 75.66 |
3,3-Diaminobenzidine (DAB) 5mg Substrate Tabs |
||
CH027 | 50 Tabs | EUR 212.4 |
3,3-Diaminobenzidine (DAB) 5mg Substrate Tabs |
||
CH028 | 100 Tabs | EUR 279.6 |
Biotin-PEO4-Propionate Succinimidyl ester: (5mg) |
||
90069 | 5MG | EUR 207.6 |
Description: Minimum order quantity: 1 unit of 5MG |
Spectropho Std Mn 5mg/L in 5% HNO3 |
||
OPS-MN5-500 | 500ML | EUR 199.76 |
5-carboxytetramethylrhodamine, SE (5-TAMRA, SE): (5mg) |
||
90034 | 5MG | EUR 276 |
Description: Minimum order quantity: 1 unit of 5MG |
6-carboxytetramethylrhodamine, SE (6-TAMRA, SE): (5mg) |
||
90035 | 5MG | EUR 276 |
Description: Minimum order quantity: 1 unit of 5MG |
Dispase Solution, 5mg/ml in DMEM/F-12 |
||
CA192-020 | 200 ml | EUR 448.8 |
5-Carboxyrhodamine 6G, hydrochloride, single isomer: (5mg) |
||
90012 | 5MG | EUR 182.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Recombinant Multi Species Buserelin Protein, Untagged, -5mg |
||
QP11214-5mg | 5mg | EUR 392.4 |
SynaptoRed C2M (also known as FM5-95): (5mg) |
||
70028 | 5MG | EUR 416.4 |
Description: Minimum order quantity: 1 unit of 5MG |
SynaptoGreen C2 (also known asl FM2-10): (5mg) |
||
70044 | 5MG | EUR 333.6 |
Description: Minimum order quantity: 1 unit of 5MG |
SynaptoGreen C18 (also known as FM3-25): (5mg) |
||
70048 | 5MG | EUR 481.2 |
Description: Minimum order quantity: 1 unit of 5MG |
Sulforhodamine 101-PEO3-amine (Texas Red-PEO3-amine): (5mg) |
||
90110 | 5MG | EUR 446.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Biotin-X NTA (Biotin-X nitrilotriacetic acid, tripotassium salt): (5mg) |
||
90056 | 5MG | EUR 190.8 |
Description: Minimum order quantity: 1 unit of 5MG |
Tetramethylrhodamine-5-isothiocyanate isomer G (5-TRITC, G isomer): (5mg) |
||
90018 | 5MG | EUR 255.6 |
Description: Minimum order quantity: 1 unit of 5MG |
Tetramethylrhodamine-6-isothiocyanate isomer R (6-TRITC, R isomer): (5mg) |
||
90019 | 5MG | EUR 255.6 |
Description: Minimum order quantity: 1 unit of 5MG |
MTS-CR110 (MTS-5-(and-6)-carboxyrhodamine 110, mixed isomers): (5mg) |
||
91035 | 5MG | EUR 277.2 |
Description: Minimum order quantity: 1 unit of 5MG |
Biotin NTA (biotin nitrilotriacetic acid, tripotassium salt; also called BNTA): (5mg) |
||
90074 | 5MG | EUR 190.8 |
Description: Minimum order quantity: 1 unit of 5MG |
5-(and-6)-Carboxyrhodamine 110-X, hydrochloride (5(6)-CR 110-X):5mg |
||
90001 | 5MG | EUR 339.6 |
Description: Minimum order quantity: 1 unit of 5MG |
5-(and-6)-Carboxyrhodamine 110-X, hydrochloride (5(6)-CR 110-X):5mg |
||
90002 | 5MG | EUR 260.4 |
Description: Minimum order quantity: 1 unit of 5MG |
MTS-CR110-X (MTS-5-(and-6)-carboxyrhodamine 110-X, mixed isomers): (5mg) |
||
91036 | 5MG | EUR 310.8 |
Description: Minimum order quantity: 1 unit of 5MG |
Dilinoleyl DiO (FAST DiO, or 1, 1'-dilinoleyl-3, 3'-oxacarbocyanine perchlorate): (5mg) |
||
60035 | 5MG | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 5MG |
5-SFX (6-(fluorescein-5-carboxamido)hexanoic acid, succinimidyl ester (single isomer):5mg |
||
90095 | 5MG | EUR 199.2 |
Description: Minimum order quantity: 1 unit of 5MG |
6-SFX (6-(fluorescein-6-carboxamido)hexanoic acid, succinimidyl ester (single isomer):5mg |
||
90096 | 5MG | EUR 199.2 |
Description: Minimum order quantity: 1 unit of 5MG |
Recombinant Rabbit TNC Protein, Untagged, Rabbit-5mg |
||
QP13765-5mg | 5mg | EUR 740.4 |
Recombinant Human Leptin Protein, Untagged, E.coli-5mg |
||
QP5350-5mg | 5mg | EUR 381.6 |
Recombinant Mouse Leptin Protein, Untagged, E.coli-5mg |
||
QP5429-5mg | 5mg | EUR 675.6 |
Recombinant Rat Leptin Protein, Untagged, E.coli-5mg |
||
QP5507-5mg | 5mg | EUR 643.2 |
Recombinant other Histrelin Protein, Untagged, E.coli-5mg |
||
QP12236-5mg | 5mg | EUR 241.2 |
Recombinant Human Leuprorelin Protein, Untagged, E.coli-5mg |
||
QP12555-5mg | 5mg | EUR 186 |
Recombinant other Lypressin Protein, Untagged, E.coli-5mg |
||
QP12608-5mg | 5mg | EUR 186 |
Recombinant other Urease Protein, Untagged, E.coli-5mg |
||
QP10907-5mg | 5mg | EUR 241.2 |
Recombinant other Antide Protein, Untagged, E.coli-5mg |
||
QP11028-5mg | 5mg | EUR 241.2 |
Recombinant other Bivalirudin Protein, Untagged, E.coli-5mg |
||
QP11165-5mg | 5mg | EUR 241.2 |
Recombinant Salmon Calcitonin Protein, Untagged, E.coli-5mg |
||
QP11261-5mg | 5mg | EUR 469.2 |
Recombinant other MOG Protein, Untagged, E.coli-5mg |
||
QP12717-5mg | 5mg | EUR 241.2 |
Recombinant Human OCT Protein, Untagged, E.coli-5mg |
||
QP12920-5mg | 5mg | EUR 337.2 |
Recombinant Human OT Protein, Untagged, E.coli-5mg |
||
QP12937-5mg | 5mg | EUR 186 |
Recombinant other Pramlintide Protein, Untagged, E.coli-5mg |
||
QP13132-5mg | 5mg | EUR 241.2 |
Recombinant Human Secretin Protein, Untagged, E.coli-5mg |
||
QP13449-5mg | 5mg | EUR 241.2 |
Recombinant Human SERPINA1 Protein, Untagged, E.coli-5mg |
||
QP13455-5mg | 5mg | EUR 914.4 |
Recombinant other Sincalide Protein, Untagged, E.coli-5mg |
||
QP13506-5mg | 5mg | EUR 241.2 |
Recombinant other Eledoisin Protein, Untagged, E.coli-5mg |
||
QP11778-5mg | 5mg | EUR 186 |
Recombinant Human Eptifibatide Protein, Untagged, E.coli-5mg |
||
QP11802-5mg | 5mg | EUR 186 |
Recombinant other Goserelin Protein, Untagged, E.coli-5mg |
||
QP12027-5mg | 5mg | EUR 175.2 |
Recombinant Human CRP Protein, Untagged, E.coli-5mg |
||
QP11513-5mg | 5mg | EUR 1698 |
Recombinant other DDAVP Protein, Untagged, E.coli-5mg |
||
QP11607-5mg | 5mg | EUR 241.2 |
Recombinant other Deslorelin Protein, Untagged, E.coli-5mg |
||
QP11661-5mg | 5mg | EUR 186 |
Recombinant Human EDN3 Protein, Untagged, E.coli-5mg |
||
QP11747-5mg | 5mg | EUR 1665.6 |
Recombinant Human GHRH Protein, Untagged, E.coli-5mg |
||
QP10643-5mg | 5mg | EUR 555.6 |
Recombinant Yeast IDH1 Protein, Untagged, Yeast-5mg |
||
QP10670-5mg | 5mg | EUR 241.2 |
Recombinant Mouse Leptin Protein, Untagged, E.coli-5mg |
||
QP10756-5mg | 5mg | EUR 620.4 |
Recombinant other Lysostaphin Protein, Untagged, E.coli-5mg |
||
QP10778-5mg | 5mg | EUR 316.8 |
5-(and-6)-Carboxyrhodamine 110-X, succinimidyl ester, hydrochloride (5(6)-CR 110-X, SE): (5mg) |
||
90003 | 5MG | EUR 368.4 |
Description: Minimum order quantity: 1 unit of 5MG |
Dilinoleyl DiI (Fast DiI, or 1, 1'-dilinoleyl-3, 3, 3', 3'-tetramethylindocarbocyanine perchlorate: (5mg) |
||
60034 | 5MG | EUR 316.8 |
Description: Minimum order quantity: 1 unit of 5MG |
Recombinant other Thymosin ?1 Protein, Untagged, E.coli-5mg |
||
QP13745-5mg | 5mg | EUR 729.6 |
Recombinant Multi Species Trp Protein, Untagged, E.coli-5mg |
||
QP13821-5mg | 5mg | EUR 195.6 |
Recombinant Human Urokinase Protein, Untagged, Native Protein-5mg |
||
QP13908-5mg | 5mg | EUR 675.6 |
Recombinant Multi Species Vasopressin Protein, Untagged, E.coli-5mg |
||
QP13923-5mg | 5mg | EUR 186 |
Recombinant Human Thrombin Protein, Untagged, Native Protein-5mg |
||
QP10880-5mg | 5mg | EUR 4027.2 |
Recombinant Human Trypsin-2 Protein, Untagged, E.coli-5mg |
||
QP10899-5mg | 5mg | EUR 241.2 |
Recombinant Human UTI Protein, Untagged, Native Protein-5mg |
||
QP10909-5mg | 5mg | EUR 186 |
Recombinant Human APOH Protein, Untagged, Native Protein-5mg |
||
QP11054-5mg | 5mg | EUR 4027.2 |
Recombinant other Streptavidin Protein, Untagged, Native Protein-5mg |
||
QP13625-5mg | 5mg | EUR 186 |
Recombinant Human GHRP 2 Protein, Untagged, E.coli-5mg |
||
QP11968-5mg | 5mg | EUR 186 |
Recombinant other GHRP 6 Protein, Untagged, E.coli-5mg |
||
QP11969-5mg | 5mg | EUR 186 |
Recombinant Bovine ECGS Protein, Untagged, Native Protein-5mg |
||
QP11736-5mg | 5mg | EUR 186 |
Recombinant Human EDN2 Protein, Untagged, Native Protein-5mg |
||
QP11746-5mg | 5mg | EUR 708 |
Recombinant other Avidin Protein, Untagged, Native Protein-5mg |
||
QP10525-5mg | 5mg | EUR 186 |
Recombinant Rat Carboxypeptidase B Protein, Untagged, E.coli-5mg |
||
QP10544-5mg | 5mg | EUR 186 |
Recombinant other hCG Protein, Untagged, Native Protein-5mg |
||
QP10664-5mg | 5mg | EUR 218.4 |
Recombinant Human MG Protein, Untagged, Native Protein-5mg |
||
QP10785-5mg | 5mg | EUR 392.4 |
Recombinant Human IGF1 Isoform 2 Protein, Untagged, E.coli-5mg |
||
QP5005-5mg | 5mg | EUR 1546.8 |
Recombinant Human IGF1 Isoform 2 Protein, Untagged, E.coli-5mg |
||
QP10392-ec-5mg | 5mg | EUR 381.6 |
Recombinant Bovine Alkaline Phosphatase Protein, Untagged, Native Protein-5mg |
||
QP10518-5mg | 5mg | EUR 316.8 |
Recombinant Mouse EGF/ Epidermal Growth Factor Protein, Untagged, E.coli-5mg |
||
QP4008-5mg | 5mg | EUR 1393.2 |
Recombinant Human EGF/ Epidermal Growth Factor Protein, Untagged, E.coli-5mg |
||
QP5334-5mg | 5mg | EUR 1393.2 |
Recombinant Human GH1/ Growth hormone 1 Protein, Untagged, E.coli-5mg |
||
QP5354-5mg | 5mg | EUR 871.2 |
Recombinant Virus Parvovirus B19 VLP VP1 Protein, Untagged, E.coli-5mg |
||
QP12966-5000ug | 5mg | EUR 795.6 |
SingleStep Poly-HRP Anti-Mouse IgG (H+L) Secondary Antibody, HRP-5mg |
||
Q2AB1-5mg | 5mg | EUR 747.6 |
SingleStep Poly-HRP Anti-Rabbit IgG (H+L) Secondary Antibody, HRP-5mg |
||
Q2AB2-5mg | 5mg | EUR 747.6 |
Recombinant S. aureus E. coli ssPA/ Stringent starvation Protein, Untagged, E.coli-5mg |
||
QP5524-5mg | 5mg | EUR 3003.6 |
HIV type 1 Glycoprotein 120 (aa 30 - 506)(MG505.W0M.ENV.A2) [His] |
||
DAG2064 | 100 µg | EUR 1095.6 |
HIV type 1 Glycoprotein 120 (aa 31 - 508)(MG505.W0M.ENV.H3) [His] |
||
DAG2065 | 100 µg | EUR 1095.6 |
MG-132 |
||
1703-25 | each | EUR 601.2 |
MG-132 |
||
1703-5 | each | EUR 210 |
MG-115 |
||
1831-1 | each | EUR 164.4 |
MG-115 |
||
1831-5 | each | EUR 326.4 |
(R)-MG132 |
||
27226 | 1 mg | EUR 130 |
Description: (R)-MG132 is a potent, cell permeable and reversible inhibitor of proteasomes. It can inhibit proteasome activity in lysates of J558L multiple myeloma cells and EMT6 breast cancer cells. In comparison to (S)-MG132, the (R)-MG132 stereoisomer is a more effective inhibitor of chymotrypsin-like (ChTL), trypsin-like (TL), and peptidylglutamyl peptide hydrolyzing proteasome (PGPH) activities. |
(S)-MG132 |
||
27230 | 10 mg | EUR 205 |
Description: (S)-MG132, also known as Z-Leu-Leu-Leu-CHO, is a potent, reversible and cell-permeable inhibitor of proteasomes that inhibits cell growth in B16 and IPC227F cells. It also inhibits NF-κB activation, sensitizing a variety of carcinoma cell lines to apoptosis. |
MG-132, >98% |
||
BC9001-005 | 5mg | EUR 198 |
MG-132, >98% |
||
BC9001-025 | 25mg | EUR 375.6 |
MG-132, >98% |
||
BC9001-100 | 100mg | EUR 886.8 |
MG-132 |
||
A2585-10 | 10 mg | EUR 129.6 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
||
A2585-100 | 100 mg | EUR 505.2 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
||
A2585-25 | 25 mg | EUR 226.8 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
||
A2585-50 | 50 mg | EUR 366 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
||
A2585-500 | 500 mg | EUR 1423.2 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-132 |
||
A2585-S | Evaluation Sample | EUR 97.2 |
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS. |
MG-115 |
||
A2612-100 | 100 mg | EUR 1034.4 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
||
A2612-25 | 25 mg | EUR 338.4 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
||
A2612-5 | 5 mg | EUR 157.2 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-115 |
||
A2612-S | Evaluation Sample | EUR 97.2 |
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy. |
MG-132 |
||
20-abx076663 |
|
|
MG-262 |
||
A8179-1 | 1 mg | EUR 338.4 |
Description: MG-262 (also known as Z-Leu-Leu-Leu-B(OH)2), a boronic peptide acid, is a potent proteasome inhibitor that selectively and reversibly inhibits the chymotryptic activity of the proteasome. |
MG-262 |
||
A8179-5 | 5 mg | EUR 1034.4 |
Description: MG-262 (also known as Z-Leu-Leu-Leu-B(OH)2), a boronic peptide acid, is a potent proteasome inhibitor that selectively and reversibly inhibits the chymotryptic activity of the proteasome. |
MG-132 |
||
E1KS2619 | 5mg1 PHYSICAL AND CHEMICAL PROPERTIES | EUR 296.4 |
MG-101 |
||
HY-18964 | 50mg | EUR 721.2 |
MG-132 |
||
HY-13259 | 10mM/1mL | EUR 135.6 |
(R)-MG-132 |
||
HY-13259C | 1mg | EUR 129.6 |
Weight Set F1 1mg-500mg & Cert |
||
87000034 | EACH | EUR 470.4 |
PS-341 (MG-341) |
||
27715-1 | 25 mg | EUR 530 |
Description: PS-341 (Pyz-Phe-boroLeu) is the active ingredient in Bortezomib. PS-341 is a reversible, cell permeable, potent, and selective proteasome inhibitor (Ki=0.6 nM). It binds the catalytic site of the 26S proteasome with high affinity and specificity. Inhibits proliferation of a number of tumor cell lines (IC50=7 nM). Inhibits TNF synthesis and FGF-induced angiogenesis. |
PS-341 (MG-341) |
||
27715-2 | 5 mg | EUR 315 |
Description: PS-341 (Pyz-Phe-boroLeu) is the active ingredient in Bortezomib. PS-341 is a reversible, cell permeable, potent, and selective proteasome inhibitor (Ki=0.6 nM). It binds the catalytic site of the 26S proteasome with high affinity and specificity. Inhibits proliferation of a number of tumor cell lines (IC50=7 nM). Inhibits TNF synthesis and FGF-induced angiogenesis. |
Nitrate Test 0.23-13.5mg per L |
||
WAT3638 | 1KIT | EUR 206.98 |
Mocetinostat (MGCD0103, MG0103) |
||
A4089-10 | 10 mg | EUR 324 |
Description: Mocetinostat, also known as MGCD0103 or MG0103, is an isotype-selective inhibitor of human histone deacetylases (HDAC), a family of enzymes involved in epigenetic regulation of gene transcription as well as cell proliferation, death and motility. |
Mocetinostat (MGCD0103, MG0103) |
||
A4089-25 | 25 mg | EUR 518.4 |
Description: Mocetinostat, also known as MGCD0103 or MG0103, is an isotype-selective inhibitor of human histone deacetylases (HDAC), a family of enzymes involved in epigenetic regulation of gene transcription as well as cell proliferation, death and motility. |
Mocetinostat (MGCD0103, MG0103) |
||
A4089-5 | 5 mg | EUR 226.8 |
Description: Mocetinostat, also known as MGCD0103 or MG0103, is an isotype-selective inhibitor of human histone deacetylases (HDAC), a family of enzymes involved in epigenetic regulation of gene transcription as well as cell proliferation, death and motility. |
Mocetinostat (MGCD0103, MG0103) |
||
A4089-5.1 | 10 mM (in 1mL DMSO) | EUR 240 |
Description: Mocetinostat, also known as MGCD0103 or MG0103, is an isotype-selective inhibitor of human histone deacetylases (HDAC), a family of enzymes involved in epigenetic regulation of gene transcription as well as cell proliferation, death and motility. |
Mocetinostat (MGCD0103, MG0103) |
||
A4089-S | Evaluation Sample | EUR 97.2 |
Description: Mocetinostat, also known as MGCD0103 or MG0103, is an isotype-selective inhibitor of human histone deacetylases (HDAC), a family of enzymes involved in epigenetic regulation of gene transcription as well as cell proliferation, death and motility. |
K-12 MG1655 Escherichia coli Strains |
||
S0042 | 100 ul | EUR 438 |
EZSolution? MG-115 |
||
2144-1 | each | EUR 164.4 |
EZSolution? MG-132 |
||
1791-5 | each | EUR 210 |
IC Anion Std Chloride 1mg/mL (1000ppm) |
||
ICAS02-C | 500ML | EUR 147.53 |
MG-63 |
||
C0004007 | One Frozen vial | EUR 546 |
Accuris F1 Grade Calibration Weight Set 1mg-200g |
||
BAL1815 | EACH | EUR 690 |
Tac-mCherry/ MG1655 Escherichia coli Strains |
||
S0114 | 100 ul | EUR 438 |
Alkalinity Std 10000mg/L 10000ppm as CaCO3 |
||
TA10M5 | 500ML | EUR 374.4 |
Alkalinity Std 4000mg/L 4000ppm as CaCO3 |
||
TA4M05 | 500ML | EUR 360 |
MG-132 Proteasome Inhibitor |
||
E1B1748 | 1mg | EUR 162 |
MG-132 (Proteasome Inhibitor) |
||
SIH-326-25MG | 25 mg | EUR 246 |
Description: The substance MG-132 is a proteasome inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble in 45 mg/ml DMSO, DMF and ethanol. |